Exosomes from K562 Human Chronic Myelogenous Leukemia Cell Line

Accelerate your exosome studies with these ready-to-use purified exosomes from the K562 human chronic myelogenous cell line.
  • High purity and integrity
  • Excellent reference protein, RNA biomarkers, and method development
  • Intact and fully functional
  • Validated by NTA and Western Blot or ELISA

Products

Catalog Number Description Size Price Quantity Add to Cart
EXOP-415A-1 Purified exosomes from K562 human chronic myelogenous leukemia cell line 50 µg $549
- +

Overview

Overview

Save time with our ready-to-use purified exosomes

Whether you’re looking for exosome standards, performing functional studies, evaluating biomarkers, or engineering exosomes for therapeutic delivery, you can get your research moving faster with our ready-to-use purified exosomes.

Prepared with quality and care

Like all of our purified exosomes, exosomes isolated from K562, a human chronic myelogenous leukemia cell line, are carefully manufactured in SBI’s Palo Alto facilities. Starting with cells grown in Exo-FBS (our exosome-depleted FBS) to maximize purity, exosomes are isolated using ExoQuick-TC® and then quality checked by Western blot and/or ELISA for the presence of TSG101, CD9, CD63, and/or CD81and NanoSight for particle size and intactness. Provided in amounts > 1 x 10^6 exosomes (or 50 µg protein equivalent), all of our preps deliver functional exosomes.

  • Ready to use - no validation required
  • Lot-to-lot QC and validation data provided with every sales unit
  • Fully standardized exosome controls

References

How It Works

Supporting Data

SBI’s Biofluid Exosomes contain expected protein markers

Figure 1. Bona fide biomarkers validated by Western blot with corresponding catalog number for each specific cell line.

NanoSight analysis of Biofluid Exosomes

Figure 2. NanoSight analysis of cell line exosomes show expected size distributions. Concentrations in particles/mL are shown, with the particle size mode reported on each plot.

FAQs

Documentation

Citations

Products

Catalog Number Description Size Price Quantity Add to Cart
EXOP-415A-1 Purified exosomes from K562 human chronic myelogenous leukemia cell line 50 µg $549
- +

Overview

Overview

Save time with our ready-to-use purified exosomes

Whether you’re looking for exosome standards, performing functional studies, evaluating biomarkers, or engineering exosomes for therapeutic delivery, you can get your research moving faster with our ready-to-use purified exosomes.

Prepared with quality and care

Like all of our purified exosomes, exosomes isolated from K562, a human chronic myelogenous leukemia cell line, are carefully manufactured in SBI’s Palo Alto facilities. Starting with cells grown in Exo-FBS (our exosome-depleted FBS) to maximize purity, exosomes are isolated using ExoQuick-TC® and then quality checked by Western blot and/or ELISA for the presence of TSG101, CD9, CD63, and/or CD81and NanoSight for particle size and intactness. Provided in amounts > 1 x 10^6 exosomes (or 50 µg protein equivalent), all of our preps deliver functional exosomes.

  • Ready to use - no validation required
  • Lot-to-lot QC and validation data provided with every sales unit
  • Fully standardized exosome controls

References

How It Works

Supporting Data

SBI’s Biofluid Exosomes contain expected protein markers

Figure 1. Bona fide biomarkers validated by Western blot with corresponding catalog number for each specific cell line.

NanoSight analysis of Biofluid Exosomes

Figure 2. NanoSight analysis of cell line exosomes show expected size distributions. Concentrations in particles/mL are shown, with the particle size mode reported on each plot.

FAQs

Citations